SONOMA PHARMACEUTICALS, INC. Share-based Payment Arrangement, Expense
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Share-based Payment Arrangement, Expense of $93.00 thousand for the 3-month period ending 2020-12-31, per its 10-Q filed 2021-02-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2021-02-16
- SONOMA PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2020-12-31 was $93.00K, a 16.96% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2020-09-30 was $160.00K, a 20.30% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2020-06-30 was $63.00K, a 78.42% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2019-12-31 was $112.00K, a 72.14% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2019 was $1.58M, a 34.61% decline from fiscal 2018.
- SONOMA PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2018 was $2.41M, a 12.35% increase from fiscal 2017.
- SONOMA PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2017 was $2.15M, a 6.03% increase from fiscal 2016.
- SONOMA PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2016 was $2.02M, a 14.23% increase from fiscal 2015.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $93.00K 10-Q · filed 2021-02-16 | $253.00K derived: sum of 2 quarters · filed 2021-02-16 | $316.00K 10-Q · filed 2021-02-16 | ||
| 2020-09-30 | $160.00K 10-Q · filed 2020-11-20 | $223.00K 10-Q · filed 2020-11-20 | |||
| 2020-06-30 | $63.00K 10-Q/A · filed 2020-11-17 | $44.00K 10-Q · filed 2020-08-14 | |||
| 2019-12-31 | $112.00K 10-Q · filed 2021-02-16 | $245.00K derived: sum of 2 quarters · filed 2021-02-16 | $537.00K 10-Q · filed 2021-02-16 | $838.00K derived: sum of 4 quarters · filed 2021-02-16 | |
| 2019-09-30 | $133.00K 10-Q · filed 2020-11-20 | $425.00K 10-Q · filed 2020-11-20 | $726.00K derived: sum of 3 quarters · filed 2020-11-20 | $1.13M derived: sum of 4 quarters · filed 2020-11-20 | |
| 2019-06-30 | $292.00K 10-Q/A · filed 2020-11-17 | $593.00K derived: sum of 2 quarters · filed 2020-11-17 | $995.00K derived: sum of 3 quarters · filed 2020-11-17 | $1.52M derived: sum of 4 quarters · filed 2020-11-17 | |
| 2019-03-31 | $301.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-01 | $703.00K derived: sum of 2 quarters · filed 2019-07-01 | $1.23M derived: sum of 3 quarters · filed 2019-07-01 | $1.58M 10-K · filed 2019-07-01 | |
| 2018-12-31 | $402.00K 10-Q · filed 2019-02-14 | $928.00K derived: sum of 2 quarters · filed 2019-02-14 | $1.27M 10-Q · filed 2019-02-14 | $2.15M derived: sum of 4 quarters · filed 2019-07-01 | |
| 2018-09-30 | $526.00K 10-Q · filed 2018-11-08 | $873.00K 10-Q · filed 2018-11-08 | $1.75M derived: sum of 3 quarters · filed 2019-07-01 | $2.42M derived: sum of 4 quarters · filed 2019-07-01 | |
| 2018-06-30 | $347.00K derived: 10-K 12 month − 3 quarters · filed 2019-07-01 | $1.23M derived: sum of 2 quarters · filed 2019-07-01 | $1.89M derived: sum of 3 quarters · filed 2019-07-01 | $2.32M derived: sum of 4 quarters · filed 2019-07-01 | |
| 2018-03-31 | $880.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-01 | $1.54M derived: sum of 2 quarters · filed 2019-07-01 | $1.97M derived: sum of 3 quarters · filed 2019-07-01 | $2.41M 10-K · filed 2019-07-01 | |
| 2017-12-31 | $665.00K 10-Q · filed 2019-02-14 | $1.09M derived: sum of 2 quarters · filed 2019-02-14 | $1.53M 10-Q · filed 2019-02-14 | ||
| 2017-09-30 | $427.00K 10-Q · filed 2018-11-08 | $865.00K 10-Q · filed 2018-11-08 | |||
| 2017-03-31 | $413.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-26 | $1.33M derived: sum of 2 quarters · filed 2018-06-26 | $1.73M derived: sum of 3 quarters · filed 2018-06-26 | $2.15M 10-K · filed 2018-06-26 | |
| 2016-12-31 | $914.00K 10-Q · filed 2018-02-14 | $1.32M derived: sum of 2 quarters · filed 2018-02-14 | $1.73M 10-Q · filed 2018-02-14 | ||
| 2016-09-30 | $406.00K 10-Q · filed 2017-11-14 | $817.00K 10-Q · filed 2017-11-14 | |||
| 2016-03-31 | $2.02M 10-K · filed 2017-06-28 | ||||
| 2015-03-31 | $417.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-21 | $864.00K derived: sum of 2 quarters · filed 2016-06-21 | $1.32M derived: sum of 3 quarters · filed 2016-06-21 | $1.77M 10-K · filed 2016-06-21 | |
| 2014-12-31 | $447.00K 10-Q · filed 2015-02-12 | $903.00K derived: sum of 2 quarters · filed 2015-02-12 | $1.35M 10-Q · filed 2015-02-12 | $1.69M derived: sum of 4 quarters · filed 2015-06-16 | |
| 2014-09-30 | $456.00K 10-Q · filed 2014-11-13 | $907.00K 10-Q · filed 2014-11-13 | $1.24M derived: sum of 3 quarters · filed 2015-06-16 | $1.53M derived: sum of 4 quarters · filed 2015-06-16 | |
| 2014-06-30 | $451.00K 10-Q · filed 2014-08-12 | $786.00K derived: sum of 2 quarters · filed 2015-06-16 | $1.08M derived: sum of 3 quarters · filed 2015-06-16 | $1.37M derived: sum of 4 quarters · filed 2015-06-16 | |
| 2014-03-31 | $335.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-16 | $626.00K derived: sum of 2 quarters · filed 2015-06-16 | $922.00K derived: sum of 3 quarters · filed 2015-06-16 | $1.11M 10-K · filed 2015-06-16 | |
| 2013-12-31 | $291.00K 10-Q · filed 2015-02-12 | $587.00K derived: sum of 2 quarters · filed 2015-02-12 | $772.00K 10-Q · filed 2015-02-12 | $977.00K derived: sum of 4 quarters · filed 2015-02-12 | |
| 2013-09-30 | $296.00K 10-Q · filed 2014-11-13 | $483.00K 10-Q · filed 2014-11-13 | $686.00K derived: sum of 3 quarters · filed 2014-11-13 | $956.00K derived: sum of 4 quarters · filed 2014-11-13 | |
| 2013-06-30 | $186.00K 10-Q · filed 2014-08-12 | $390.00K derived: sum of 2 quarters · filed 2014-08-12 | $660.00K derived: sum of 3 quarters · filed 2014-08-12 | $1.03M derived: sum of 4 quarters · filed 2014-08-12 | |
| 2013-03-31 | $204.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-30 | $474.00K derived: sum of 2 quarters · filed 2014-06-30 | $846.00K derived: sum of 3 quarters · filed 2014-06-30 | $1.15M 10-K · filed 2014-06-30 | |
| 2012-12-31 | $270.00K 10-Q · filed 2014-02-14 | $642.00K derived: sum of 2 quarters · filed 2014-02-14 | $950.00K 10-Q · filed 2014-02-14 | ||
| 2012-09-30 | $372.00K 10-Q · filed 2013-11-19 | $680.00K 10-Q · filed 2013-11-19 | |||
| 2012-06-30 | $308.00K 10-Q · filed 2013-08-14 | ||||
| 2012-03-31 | $2.17M 10-K · filed 2013-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |